Recent observations of rodent HCC showed that sunitinib significantly reduced the frequency and function of tumor-infiltrating Tregs, which recovered the cytotoxicity of tumor-specific CD8+ T cells [81]. This evidence concerns the gene CD8A and neoplasm.